{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:28:04Z","timestamp":1771486084142,"version":"3.50.1"},"reference-count":98,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Lymph node management in cutaneous melanoma has undergone a paradigm shift, transitioning from routine complete lymph node dissection (CLND) to a more selective, individualized approach. This narrative review explores the historical evolution, current evidence and clinical guidelines surrounding lymphadenectomy for a patient with Stage III of melanoma. Materials and Methods: A comprehensive literature search was conducted across PubMed, Scopus and Web of Science, focusing on randomized controlled trials, meta-analyses and updated international guidelines published in the past 15 years. Results: Traditional surgical approaches favored radical lymphadenectomy for regional disease control. However, pivotal trials such as the Multicenter Selective Lymphadenectomy Trial II (MSLT-II) and German Dermatologic Cooperative Oncology Group Selective Lymphadenectomy Trial (DeCOG-SLT) demonstrated no survival advantage from immediate CLND following a positive sentinel lymph node biopsy (SLNB), underscoring increased surgical morbidity. Consequently, guidelines from Associazione Italiana di Oncologia Medica (AIOM), the European Society for Medical Oncology (ESMO), and the National Comprehensive Cancer Network (NCCN) now endorse SLNB as the standard for nodal staging, reserving CLND for select high-risk cases. Conclusions: The role of lymphadenectomy in melanoma is increasingly becoming selective, shaped by tumor burden, nodal involvement and response to systemic therapy. SLNB remains central to staging and treatment planning, while CLND is no longer routine. Continued clinical trials and integration with immunotherapy will further refine surgical strategies in melanoma care.<\/jats:p>","DOI":"10.3390\/medicina61091722","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T13:04:44Z","timestamp":1758546284000},"page":"1722","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rethinking Lymphadenectomy in Cutaneous Melanoma: From Routine Practice to Selective Indication: A Narrative Review"],"prefix":"10.3390","volume":"61","author":[{"given":"Matteo","family":"Matteucci","sequence":"first","affiliation":[{"name":"Department of General Surgery, University of Milan, 20122 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7560-551X","authenticated-orcid":false,"given":"Antonio","family":"Pesce","sequence":"additional","affiliation":[{"name":"Department of Surgery, Azienda Unit\u00e0 Sanitaria Locale (AUSL) Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7668-3042","authenticated-orcid":false,"given":"Salvatore","family":"Guarino","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Multimedica Sesto San Giovanni, 20099 Sesto San Giovanni, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1118-9817","authenticated-orcid":false,"given":"Diletta","family":"Cassini","sequence":"additional","affiliation":[{"name":"ASST Nord Milano-Department of General and Rery, Sesto San Giovanni Hospital, 20099 Sesto San Giovanni, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1889-2644","authenticated-orcid":false,"given":"Bruno","family":"Cirillo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Sapienza University, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Boselli","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5709-2530","authenticated-orcid":false,"given":"Vito","family":"D\u2019Andrea","sequence":"additional","affiliation":[{"name":"Department of Surgery, Sapienza University, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8786-7007","authenticated-orcid":false,"given":"Marco","family":"Artico","sequence":"additional","affiliation":[{"name":"Department of Sensory Organs, Sapienza University, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Forte","sequence":"additional","affiliation":[{"name":"Department of Sensory Organs, Sapienza University, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7998-5161","authenticated-orcid":false,"given":"Piero","family":"Covarelli","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2457-0636","authenticated-orcid":false,"given":"Roberto","family":"Cirocchi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.det.2012.04.001","article-title":"Update on the current state of melanoma incidence","volume":"30","author":"Little","year":"2012","journal-title":"Dermatol. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jaad.2011.04.032","article-title":"Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992\u20132006","volume":"65","author":"Jemal","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"ref_4","unstructured":"AIOM (2023). Linee Guida AIOM per il Trattamento del Melanoma, Associazione Italiana di Oncologia Medica. Available online: https:\/\/www.aiom.it\/linee-guida-aiom\/."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/phpp.12329","article-title":"Mechanisms and prevention of UV-induced melanoma","volume":"34","author":"Sample","year":"2018","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Slominski, R.M., Sarna, T., P\u0142onka, P.M., Raman, C., Bro\u017cyna, A.A., and Slominski, A.T. (2022). Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.842496"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"ref_9","unstructured":"Cancer Genome Atlas Network (2015). Genomic Classification of Cutaneous Melanoma. Cell, 161, 1681\u20131696."},{"key":"ref_10","first-page":"705","article-title":"The histogenesis and biologic behavior of primary human malignant melanomas of the skin","volume":"29","author":"Clark","year":"1969","journal-title":"Cancer Res."},{"key":"ref_11","first-page":"1707","article-title":"Neuklassifizierung des malignen Melanoms. Grundlagen und praktische Bedeutung [New classification of malignant melanoma. Basic concepts and practical significance]","volume":"71","author":"Kalkoff","year":"1976","journal-title":"Med. Klin."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ferrara, G., and Argenziano, G. (2021). The WHO 2018 Classification of Cutaneous Melanocytic Neoplasms: Suggestions From Routine Practice. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.675296"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/00313028609090822","article-title":"The classification of malignant melanoma, its histological reporting and registration: A revision of the 1972 Sydney classification","volume":"18","author":"McGovern","year":"1986","journal-title":"Pathology"},{"key":"ref_14","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/cncr.34824","article-title":"The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup","volume":"129","author":"Patuzzo","year":"2023","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1245\/s10434-014-4349-3","article-title":"Tumor mitotic rate added to the equation: Melanoma prognostic factors changed?: A single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients","volume":"22","author":"Speijers","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaad.2015.09.014","article-title":"A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas","volume":"74","author":"Wat","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_18","first-page":"1165","article-title":"Survival in Patients With Sentinel Node-Positive Melanoma With Extranodal Extension","volume":"19","author":"Maurichi","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejso.2016.08.007","article-title":"Sentinel node biopsy in melanoma: Current controversies addressed","volume":"43","author":"Madu","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10585-020-10028-0","article-title":"Sentinel node tumor burden in prediction of prognosis in melanoma patients","volume":"37","author":"Palve","year":"2020","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1200\/JCO.21.02488","article-title":"Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease","volume":"40","author":"Moncrieff","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-319-22539-5_6","article-title":"Surgical Management of Melanoma","volume":"Volume 167","author":"Koshenkov","year":"2016","journal-title":"Cancer Treatment and Research"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.clindermatol.2008.09.017","article-title":"Sentinel lymph node biopsy from the vantage point of an oncologic surgeon","volume":"27","author":"Wilson","year":"2009","journal-title":"Clin. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1024\/1661-8157\/a000613","article-title":"Die Rolle der Chirurgie in der Behandlung des kutanen Melanoms [The role of surgery in the treatment of cutaneous melanoma]","volume":"100","author":"Guggenheim","year":"2011","journal-title":"Praxis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2217\/fon.13.245","article-title":"Sentinel lymph node biopsy in melanoma: Controversies and current guidelines","volume":"10","author":"Durham","year":"2014","journal-title":"Future Oncol."},{"key":"ref_26","first-page":"884","article-title":"Belangrijke prognostische betekenis van schildwachtklierbiopsie bij pati\u00ebnten met maligne melanoom [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma]","volume":"148","author":"Keijzer","year":"2004","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"ref_27","unstructured":"European Society for Medical Oncology (ESMO) (2025, June 01). Cutaneous Melanoma: ESMO Clinical Practice Guidelines. Available online: https:\/\/www.esmo.org\/guidelines."},{"key":"ref_28","unstructured":"National Comprehensive Cancer Network (NCCN) (2025, June 01). NCCN Clinical Practice Guidelines in Oncology: Melanoma, Version 2.2024. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/melanoma.pdf."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.18.02306","article-title":"Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node","volume":"37","author":"Leiter","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_31","unstructured":"Handley, W.S. (1907). The Pathology of Melanotic Growths in Relation to Their Operative Treatment. Lancet, 1."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000658-199609000-00002","article-title":"Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger","volume":"224","author":"Balch","year":"1996","journal-title":"Ann. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000658-198309000-00014","article-title":"Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma","volume":"198","author":"Reintgen","year":"1983","journal-title":"Ann. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s001050050371","article-title":"Elektive Lymphknoten-dissektion bei prim\u00e4rem malignen Melanom [Elective lymph node dissection in primary malignant melanoma]","volume":"47","author":"Petres","year":"1996","journal-title":"Hautarzt"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1098-2388(199806)14:4<276::AID-SSU3>3.0.CO;2-#","article-title":"Role of elective lymph node dissection in melanoma","volume":"14","author":"Hochwald","year":"1998","journal-title":"Semin. Surg. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hed.20749","article-title":"Dilemma of clinically node-negative head and neck melanoma: Outcome of \u201cwatch and wait\u201d policy, elective lymph node dissection, and sentinel node biopsy--a systematic review","volume":"30","author":"Tanis","year":"2008","journal-title":"Head Neck"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00005537-200201000-00018","article-title":"Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: Analysis of 1444 patients from 1970 to 1998","volume":"112","author":"Fisher","year":"2002","journal-title":"Laryngoscope"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2003-36906","article-title":"Kutane maligne Melanome der Kopf-Hals-Region mit intermedi\u00e4rer Tumordicke: Die Bedeutung der elektiven Versorgung der Lymphabflusswege im klinischen Stadium I [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: The role of elective lymph node dissection for clinical stage I]","volume":"82","author":"Wenzel","year":"2003","journal-title":"Laryngorhinootologie"},{"key":"ref_39","first-page":"869","article-title":"Melanotic cancerous disease","volume":"140","author":"Snow","year":"1982","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO;2-A","article-title":"Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy","volume":"1","author":"Brunschwig","year":"1948","journal-title":"Cancer"},{"key":"ref_41","first-page":"719","article-title":"Surgical management of patients with intermediate thickness melanoma: Current role of elective lymph node dissection","volume":"23","author":"Cole","year":"1996","journal-title":"Semin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archsurg.137.4.458","article-title":"Elective lymph node dissection in patients with melanoma: Systematic review and meta-analysis of randomized controlled trials","volume":"137","author":"Lens","year":"2002","journal-title":"Arch. Surg."},{"key":"ref_43","first-page":"129","article-title":"Elective lymph node dissection in melanoma: Still a controversial issue","volume":"43","author":"Kroon","year":"1991","journal-title":"Neth. J. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF02071522","article-title":"Elective lymph node dissection for melanoma: Two perspectives","volume":"16","author":"McCarthy","year":"1992","journal-title":"World J. Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archderm.1997.03890440073012","article-title":"Theoretical and empirical arguments in relation to elective lymph node dissection for melanoma","volume":"133","author":"Piepkorn","year":"1997","journal-title":"Arch. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1072-7515(99)00128-3","article-title":"The role of elective lymph node dissection in malignant melanoma: Who should undergo this nodal staging procedure?","volume":"189","author":"Reintgen","year":"1999","journal-title":"J. Am. Coll. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0889-8588(05)70024-1","article-title":"Lymphatic mapping and selective lymphadenectomy as an alternative to elective lymph node dissection in patients with malignant melanoma","volume":"12","author":"Reintgen","year":"1998","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_48","first-page":"101","article-title":"Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1\u20134 mm melanomas","volume":"8","author":"Balch","year":"2001","journal-title":"Ann. Surg. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","article-title":"Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial","volume":"351","author":"Cascinelli","year":"1998","journal-title":"Lancet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch. Surg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.soc.2020.02.006","article-title":"Sentinel Lymph Node Biopsy: Indications and Technique","volume":"29","author":"Crystal","year":"2020","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_52","first-page":"811","article-title":"Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma","volume":"43","author":"Mariani","year":"2002","journal-title":"J. Nucl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jso.20027","article-title":"Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: The nuclear medicine contribution","volume":"85","author":"Mariani","year":"2004","journal-title":"J. Surg. Oncol."},{"key":"ref_54","first-page":"181","article-title":"Sentinel node identification by scintigraphic methods in cutaneous melanoma","volume":"24","author":"Resende","year":"2005","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_55","first-page":"234","article-title":"The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: An Italian Multicentric Study (SOLISM-IMI)","volume":"47","author":"Rossi","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/00005537-200108000-00010","article-title":"Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: Preliminary study","volume":"111","author":"Rasgon","year":"2001","journal-title":"Laryngoscope"},{"key":"ref_57","first-page":"147","article-title":"Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning","volume":"28","author":"Robinson","year":"1977","journal-title":"Surg. Forum."},{"key":"ref_58","first-page":"626","article-title":"The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: A preliminary study","volume":"84","author":"Fee","year":"1978","journal-title":"Surgery"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1200\/JCO.1993.11.9.1751","article-title":"Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck","volume":"11","author":"Morton","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0001-2998(00)80061-6","article-title":"Melanoma lymphoscintigraphy and lymphatic mapping","volume":"30","author":"Berman","year":"2000","journal-title":"Semin. Nucl. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10434-999-0345-4","article-title":"Cutaneous lymphatic drainage in patients with grossly involved nodal basins","volume":"6","author":"Kamath","year":"1999","journal-title":"Ann. Surg. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1200\/JCO.2010.33.1884","article-title":"Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: A meta-analysis","volume":"29","author":"Valsecchi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0039-6060(98)70121-7","article-title":"Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid","volume":"124","author":"Gershenwald","year":"1998","journal-title":"Surgery"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1200\/JCO.2013.50.7681","article-title":"Nonsentinel lymph node status in patients with cutaneous melanoma: Results from a multi-institution prognostic study","volume":"32","author":"Pasquali","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjsurg.2018.01.033","article-title":"Patients with sentinel lymph node positive melanoma: Who needs completion lymph node dissection?","volume":"215","author":"Schuitevoerder","year":"2018","journal-title":"Am. J. Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_67","first-page":"35","article-title":"Management of lower limb lymphedema following lymphadenectomy for melanoma","volume":"36","author":"Vasiliadou","year":"2018","journal-title":"J. Vasc. Nurs."},{"key":"ref_68","first-page":"2100","article-title":"Regional lymph node basin recurrence and lymphedema following complete lymph node dissection for melanoma","volume":"23","author":"Fields","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_69","first-page":"473","article-title":"Surgical complications and quality of life after inguinal versus axillary lymph node dissection for cutaneous melanoma","volume":"21","author":"Kirkley","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_70","first-page":"2891","article-title":"Complications associated with groin dissection in melanoma patients","volume":"22","author":"Leung","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_71","first-page":"1171","article-title":"Groin lymphadenectomy in melanoma: A prospective multicenter study (GOLM study)","volume":"26","author":"Petrillo","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_72","first-page":"615","article-title":"Nerve injury associated with axillary lymph node dissection for melanoma: Incidence and clinical implications","volume":"107","author":"Carson","year":"2013","journal-title":"J. Surg. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12967-019-2012-2","article-title":"New paradigm for stage III melanoma: From surgery to adjuvant treatment","volume":"17","author":"Ascierto","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejca.2017.09.014","article-title":"The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients","volume":"86","author":"Eggermont","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1470-2045(18)30015-9","article-title":"Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: A single-centre, open-label, randomised, phase 2 trial","volume":"19","author":"Amaria","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1470-2045(18)30016-0","article-title":"Neoadjuvant therapy in melanoma: The next step?","volume":"19","author":"Ascierto","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s11864-024-01239-8","article-title":"Advancements in Melanoma Therapies: From Surgery to Immunotherapy","volume":"25","author":"Shajari","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-031-97242-3_9","article-title":"Immunotherapy in Melanoma","volume":"129","author":"Xing","year":"2025","journal-title":"Cancer Treat. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1470-2045(21)00065-6","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG\/KEYNOTE-054): Distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial","volume":"22","author":"Eggermont","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S1470-2045(20)30494-0","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial","volume":"21","author":"Ascierto","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S1470-2045(19)30151-2","article-title":"Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): A multicentre, phase 2, randomised, controlled trial","volume":"20","author":"Rozeman","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-022-01851-x","article-title":"Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: The PRADO trial","volume":"28","author":"Reijers","year":"2022","journal-title":"Nat Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"van Akkooi, A., Ariyan, C., and Moncrieff, M. (2025). Melanoma Great Debate: Targeted Versus Complete Nodal Dissection Following Neoadjuvant Therapy for Melanoma: Is it Time to Push Forward or Hold Off on Continued De-Escalation of Surgery?. Ann. Surg. Oncol.","DOI":"10.1245\/s10434-025-18163-2"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jss.2013.10.037","article-title":"Accuracy and prognostic value of sentinel lymph node biopsy in head and neck melanomas","volume":"187","author":"Patuzzo","year":"2014","journal-title":"J. Surg. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e24284","DOI":"10.1097\/MD.0000000000024284","article-title":"Sentinel lymph node biopsy in head and neck cutaneous melanomas: A PRISMA-compliant systematic review and meta-analysis","volume":"100","author":"Zhang","year":"2021","journal-title":"Medicine"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/lary.23793","article-title":"Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp","volume":"123","author":"Cappello","year":"2013","journal-title":"Laryngoscope"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"941921","DOI":"10.1155\/2012\/941921","article-title":"Review of diagnostic imaging modalities for the surveillance of melanoma patients","volume":"2012","author":"Xing","year":"2012","journal-title":"Dermatol. Res. Pract."},{"key":"ref_89","unstructured":"National Institute for Health and Care Excellence (NICE) (2022). Evidence Reviews for the Follow-Up of People with Melanoma: Melanoma: Assessment and Management: Evidence Review G."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/CMR.0b013e328348dad3","article-title":"Lymph node ultrasound during melanoma follow-up significantly improves metastasis detection compared with clinical examination alone: A study on 433 patients","volume":"21","author":"Kretschmer","year":"2011","journal-title":"Melanoma Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamasurg.2021.7554","article-title":"Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients with Stage III Melanoma","volume":"157","author":"Reijers","year":"2022","journal-title":"JAMA Surg."},{"key":"ref_92","unstructured":"(2025, June 01). Available online: https:\/\/www.ctg.queensu.ca\/public\/melanoma\/melanoma-disease-site."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma","volume":"388","author":"Patel","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa2402604","article-title":"Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma","volume":"391","author":"Blank","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.0022-202x.2001.01421.x","article-title":"Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color","volume":"117","author":"Kennedy","year":"2001","journal-title":"J. Investig. Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/pcmr.13114","article-title":"Histopathologic abundance of pigmentation correlates with disease-specific survival in malignant melanoma but is not independent of current AJCC pT stage","volume":"36","author":"Aebischer","year":"2023","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.humpath.2013.02.022","article-title":"Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma","volume":"44","author":"Carlson","year":"2013","journal-title":"Hum. Pathol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"17844","DOI":"10.18632\/oncotarget.7528","article-title":"Melanin content in melanoma metastases affects the outcome of radiotherapy","volume":"7","author":"Roszkowski","year":"2016","journal-title":"Oncotarget"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1722\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:47:07Z","timestamp":1760035627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":98,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medicina61091722"],"URL":"https:\/\/doi.org\/10.3390\/medicina61091722","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]}}}